Filing Details
- Accession Number:
- 0001333277-18-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-31 19:24:00
- Reporting Period:
- 2018-08-29
- Accepted Time:
- 2018-08-31 19:24:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1042074 | Cymabay Therapeutics Inc. | CBAY | Pharmaceutical Preparations (2834) | 943103561 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1705745 | Daniel Menold | C/O Cymabay Therapeutics, Inc. 7999 Gateway Boulevard Newark CA 94560 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-29 | 5,000 | $5.00 | 5,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-29 | 5,000 | $13.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-08-29 | 5,000 | $0.00 | 5,000 | $5.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,459 | 2024-01-21 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The option vested as to 1/4 of the shares on January 22, 2015 and 1/36 per month thereafter.